PPD IPOs 69.0M* shares @$27.00—proceeds will be used to pay off debt: https://www.businesswire.com/news/home/20200205005872/en PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Our customers include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 46 countries and approximately 23,000 professionals worldwide… Clearly, PPD is no startup, LOL. *Assuming exercise of underwriter’s option.